Indian Firm Buys U.K. Pharma Company

Marksans Pharma (Mumbai) says it has signed an agreement to acquire 100% of Hale Group (Widnes, U.K.), the parent of Bell, Sons & Co. Druggists Ltd. (Widnes). Financial terms of the acquisition were not disclosed. Marksans Pharma manufactures and sells active pharmaceutical ingredients, intermediates, and formulation drugs. Marksans exports about 40% of its output to markets including Africa, Bangladesh, Germany, Iran, Japan, Jordan, Latin America, and Spain. Acquiring Bell establishes Marksans in the U.K. market and gives Marksans access to 34 additional...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers